Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer
Authors
Keywords
-
Journal
JAMA Oncology
Volume 7, Issue 8, Pages 1133
Publisher
American Medical Association (AMA)
Online
2021-05-29
DOI
10.1001/jamaoncol.2021.2155
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of sixteen serological SARS-CoV-2 immunoassays in sixteen clinical laboratories
- (2021) Lene H. Harritshøj et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
- (2021) Charlotte Manisty et al. LANCET
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
- (2021) Noa Dagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection
- (2021) Raymond A. Harvey et al. JAMA Internal Medicine
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
- (2020) Nicole M Kuderer et al. LANCET
- Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer: the view from primary care
- (2020) Daniel Jones et al. LANCET ONCOLOGY
- The Untold Toll — The Pandemic’s Effects on Patients without Covid-19
- (2020) Lisa Rosenbaum NEW ENGLAND JOURNAL OF MEDICINE
- Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test
- (2020) Silvia Meschi et al. JOURNAL OF CLINICAL VIROLOGY
- Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
- (2020) Marina Pollán et al. LANCET
- Determinants of COVID-19 disease severity in patients with cancer
- (2020) Elizabeth V. Robilotti et al. NATURE MEDICINE
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- (2020) Ugur Sahin et al. NATURE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited
- (2020) Antoni Ribas et al. Cancer Discovery
- 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
- (2013) Lorry G. Rubin et al. CLINICAL INFECTIOUS DISEASES
- Response to influenza virus vaccination during chemotherapy in patients with breast cancer
- (2011) A. Meerveld-Eggink et al. ANNALS OF ONCOLOGY
- Low influenza vaccination rate among patients receiving chemotherapy for cancer
- (2008) P. Loulergue et al. ANNALS OF ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started